Kaiji Hu
Vancouver, BC V5Z1L3, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Response to Comment on "PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL+ human leukemia".
Journal: Science translational medicine
Published: August 12, 2018
A knock-in mouse strain facilitates dynamic tracking and enrichment of MEIS1.
Journal: Blood advances
Published: July 10, 2017
PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL+ human leukemia.
Journal: Science translational medicine
Published: May 31, 2017
YB-1 transforms human mammary epithelial cells through chromatin remodeling leading to the development of basal-like breast cancer.
Journal: Stem cells (Dayton, Ohio)
Published: April 05, 2013
Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.
Journal: Oncotarget
Published: January 19, 2013
Disulfiram, a drug widely used to control alcoholism, suppresses the self-renewal of glioblastoma and over-rides resistance to temozolomide.
Journal: Oncotarget
Published: October 11, 2012
Targeting p90 ribosomal S6 kinase eliminates tumor-initiating cells by inactivating Y-box binding protein-1 in triple-negative breast cancers.
Journal: Stem cells (Dayton, Ohio)
Published: June 08, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026